BANK OF MONTREAL /CAN/ - TENAX THERAPEUTICS INC ownership

TENAX THERAPEUTICS INC's ticker is TENX and the CUSIP is 88032L100. A total of 38 filers reported holding TENAX THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of TENAX THERAPEUTICS INC
ValueSharesWeighting
Q1 2016$020.0%0.00%
Q4 2015$0
-100.0%
2
-99.5%
0.00%
Q3 2015$1,0000.0%402
+0.5%
0.00%
Q2 2015$1,0000.0%4000.0%0.00%
Q1 2015$1,000
-50.0%
4000.0%0.00%
Q4 2014$2,0000.0%4000.0%0.00%
Q3 2014$2,0004000.00%
Other shareholders
TENAX THERAPEUTICS INC shareholders Q3 2015
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,108,593$3,326,0001.32%
RA Capital Management 2,670,300$8,011,0001.15%
Opaleye Management Inc. 635,000$1,905,0000.94%
Broadfin Capital, LLC 1,968,631$5,906,0000.33%
SABBY MANAGEMENT, LLC 2,604,660$7,892,0000.32%
DAFNA Capital Management LLC 81,509$245,0000.24%
ARMISTICE CAPITAL, LLC 88,739$266,0000.09%
BOURGEON CAPITAL MANAGEMENT LLC 17,500$52,0000.04%
Verition Fund Management LLC 25,640$78,0000.02%
COMMERZBANK AKTIENGESELLSCHAFT /FI 738,592$2,216,0000.02%
View complete list of TENAX THERAPEUTICS INC shareholders